Cite
Symptomatic intracerebral hemorrhage among eligible warfarin-treated patients receiving intravenous tissue plasminogen activator for acute ischemic stroke
MLA
Shyam Prabhakaran, et al. “Symptomatic Intracerebral Hemorrhage among Eligible Warfarin-Treated Patients Receiving Intravenous Tissue Plasminogen Activator for Acute Ischemic Stroke.” Archives of Neurology, vol. 67, no. 5, Mar. 2010. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....9ec6b8d9d742f06de81ff9d94c74bb9b&authtype=sso&custid=ns315887.
APA
Shyam Prabhakaran, Randolph S. Marshall, Juan Rivolta, Ji Y. Chong, Joshua Stillman, Fred Rincon, & Julio R. Vieira. (2010). Symptomatic intracerebral hemorrhage among eligible warfarin-treated patients receiving intravenous tissue plasminogen activator for acute ischemic stroke. Archives of Neurology, 67(5).
Chicago
Shyam Prabhakaran, Randolph S. Marshall, Juan Rivolta, Ji Y. Chong, Joshua Stillman, Fred Rincon, and Julio R. Vieira. 2010. “Symptomatic Intracerebral Hemorrhage among Eligible Warfarin-Treated Patients Receiving Intravenous Tissue Plasminogen Activator for Acute Ischemic Stroke.” Archives of Neurology 67 (5). http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....9ec6b8d9d742f06de81ff9d94c74bb9b&authtype=sso&custid=ns315887.